Market Research Industry Reports

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Karo Pharma AB (Karo Pharma), formerly Karo Bio AB, is a health care company that focuses on research and development of pharmaceutical products in the areas of cancer and autoimmune diseases. Its key research area involves nuclear receptors as target proteins for the development of new pharmaceuticals. Karo Pharma discovers drugs to target major diseases including autoimmune diseases such as multiple sclerosis; and multiple types of cancer, viral and bacterial infections. The companys projects are based on ROR gamma receptor and estrogen receptor. Its development pipeline also includes T268A Cold Spray which utilizes glucose oxidase enzyme in combination with glucose to fight against cold virus. Karo Pharma is headquartered in Huddinge, Stockholm, Sweden.

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Karo Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Karo Pharma AB, Medical Devices Deals, 2012 to YTD 2018 10
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Karo Pharma AB, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Karo Pharma to Acquire Product Portfolio of Ten Products from LEO Pharma for USD317.6 Million 12
Partnerships 14
Karo Bio Enters Into Research Agreement With 4D Science 14
Licensing Agreements 15
Karo Bio Enters into Licensing Agreement with Pelago Bioscience for CETSA 15
Equity Offering 16
Karo Bio to Raise USD29.7 Million in Rights Offering of Preferred Shares 16
Karo Bio Raises USD29 Million in Rights Offering of Shares 18
Karo Bio Raises USD12 Million in Rights Offering of Shares 19
Karo Bio Raises USD1 Million in Private Placement of Shares 20
Karo Bio Completes Rights Offering of Shares for USD4.9 Million 21
Asset Transactions 22
Oasmia Pharma Acquires Cancer Project KB9520 from Karo Pharma 22
Acquisition 23
Karo Pharma Acquires Weifa 23
Karo Pharma Acquires 100% Stake in Medireduce 25
Karo Pharma Acquires BioPhausia from Medivir for USD95 Million 26
Karo Bio Acquires Tanomed for USD2.3 Million 27
Karo Pharma AB - Key Competitors 28
Karo Pharma AB - Key Employees 29
Karo Pharma AB - Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
Feb 22, 2018: Karo Pharma: Year-end Report 2017 31
Nov 02, 2017: Karo Pharma: Interim Report January September 2017 32
Aug 24, 2017: Karo Pharma: Interim Report JanuaryJune 2017 34
May 10, 2017: Karo Pharma: interim report January - March-2017 35
Feb 28, 2017: Karo Pharma: Full Year Report 2016 36
Corporate Communications 37
Mar 23, 2018: Karo Pharma Supports Operation Smile 37
Other Significant Developments 38
May 04, 2017: Karo Pharma - Pfizer Collaboration reaches second milestone 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List Of Tables

List of Tables
Karo Pharma AB, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Karo Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Karo Pharma AB, Deals By Therapy Area, 2012 to YTD 2018 8
Karo Pharma AB, Medical Devices Deals, 2012 to YTD 2018 10
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Karo Pharma to Acquire Product Portfolio of Ten Products from LEO Pharma for USD317.6 Million 12
Karo Bio Enters Into Research Agreement With 4D Science 14
Karo Bio Enters into Licensing Agreement with Pelago Bioscience for CETSA 15
Karo Bio to Raise USD29.7 Million in Rights Offering of Preferred Shares 16
Karo Bio Raises USD29 Million in Rights Offering of Shares 18
Karo Bio Raises USD12 Million in Rights Offering of Shares 19
Karo Bio Raises USD1 Million in Private Placement of Shares 20
Karo Bio Completes Rights Offering of Shares for USD4.9 Million 21
Oasmia Pharma Acquires Cancer Project KB9520 from Karo Pharma 22
Karo Pharma Acquires Weifa 23
Karo Pharma Acquires 100% Stake in Medireduce 25
Karo Pharma Acquires BioPhausia from Medivir for USD95 Million 26
Karo Bio Acquires Tanomed for USD2.3 Million 27
Karo Pharma AB, Key Competitors 28
Karo Pharma AB, Key Employees 29
Karo Pharma AB, Subsidiaries 30

List Of Figures

List of Figures
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Karo Pharma AB, Medical Devices Deals, 2012 to YTD 2018 10

Karo Pharma AB (KARO) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Karo Pharma AB (Karo Pharma), formerly Karo Bio AB, is a health care company that focuses on research and development of pharmaceutical products in the areas of cancer and autoimmune

USD 250View Report

Karo Pharma AB (KARO) - Financial and Strategic SWOT Analysis Review

Karo Pharma AB (KARO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125View Report

Karo Pharma AB (KARO) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Karo Pharma AB (Karo Pharma), formerly Karo Bio AB, is a health care company that focuses on research and development of pharmaceutical products in the areas of cancer and autoimmune

USD 250View Report

Xbrane Biopharma AB (XBRANE) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products. The companys product portfolio includes biosimilars and long acting injectables developed

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :39
Country :Sweden
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube